findmyKOL

Amy Cummings

Basic profile

APLA Health

ORCIDNPI
RegionTorrance, CA · WestSpecialtyHematology / OncologyFocusOncology
Active KOLEmergingfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Amy Cummings is an Oncology physician affiliated with APLA Health. OpenAlex indexes 206 publications with 1,458 citations (h-index 14).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
206publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,458citations

Total citations across indexed works.

14h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
18companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

3445 Pacific Coast Hwy Ste 300
Torrance, CA 905056660

Telephone

310-325-8252

Provider last certified this registry record 8 Aug 2024.

View the NPPES registry record

Industry payments

18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    42.6%
    Serotonin-3 Receptor Antagonist37.6%
    Ondansetron hydrochloride93%Ondansetron Odt7%
    Part D + Part B<11 patients
    Proton pump inhibitor3.1%
    Pantoprazole Sodium100%
    Part D12 patients

    + 1 more class in this area

  • Cancer & immunology

    17%
    Kinase inhibitor12%
    Tagrisso100%
    Part D<11 patients
    Thalidomide Analog3.5%
    Lenalidomide50%Pomalyst50%
    Part D<11 patients

    + 1 more class in this area

  • Musculoskeletal

    11.8%
    Bisphosphonate11.8%
    Zoledronic acid100%
    Part B, office-administered18 patients
Where care is delivered (Part B)4.2% facility · 95.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”